Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells-Reference-Cited by-同舟云学术

Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells

Published:2017-03-13 Issue:1 Volume:10 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Qin Le,Lai Yunxin,Zhao Ruocong,Wei Xinru,Weng Jianyu,Lai Peilong,Li Baiheng,Lin Simiao,Wang Suna,Wu Qiting,Liang Qiubin,Li Yangqiu,Zhang Xuchao,Wu Yilong,Liu Pentao,Yao Yao,Pei Duanqing,Du Xin,Li Peng

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-017-0437-8.pdf

Reference52 articles.

1. Park JH, Geyer MB, Brentjens RJ. CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date. Blood. 2016;127(26):3312–20.

2. Jackson HJ, Rafiq S, Brentjens RJ. Driving CAR T-cells forward. Nat Rev Clin Oncol. 2016;13(6):370–83.

3. Cheadle EJ, Gornall H, Baldan V, Hanson V, Hawkins RE, Gilham DE. CAR T cells: driving the road from the laboratory to the clinic. Immunol Rev. 2014;257(1):91–106.

4. Cai B, Guo M, Wang Y, Zhang Y, Yang J, Guo Y, Dai H, Yu C, Sun Q, Qiao J, et al. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia. J Hematol Oncol. 2016;9(1):131.

5. Barrett DM, Grupp SA, June CH. Chimeric antigen receptor- and TCR-modified T cells enter main street and wall street. J Immunol. 2015;195(3):755–61.

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing CAR T cells function: role of immunomodulators in cancer immunotherapy;Clinical and Experimental Medicine;2024-08-06

2. Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells;Cancer Immunology Research;2024-05-30

3. Recent Updates on Chimeric Antigen Receptor T-Cell Approaches in Cancer Immunotherapy;Advances in Cancer Immunotherapy [Working Title];2024-05-15

4. State of the art and perspectives of CAR-T cell therapy for neuroblastoma;Cytotherapy;2024-05

5. Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances;Journal of Controlled Release;2024-04